Skip to main content
. 2025 Aug 6;32(8):441. doi: 10.3390/curroncol32080441
pCR Pathological complete response
DFS Disease-free survival
OS Overall survival
EC Epirubicin/cyclophosphamide
NAC Neoadjuvant chemotherapy
TNBC Triple-negative breast cancer
G-CSF Granulocyte-colony stimulating factor
PD-L1 Programmed cell death ligand 1
IMP3 Insulin-like growth factor II mRNA-binding protein 3